Implant Sciences Cp (IMSC) 0.3090 $IMSC Implant Sciences

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Implant Sciences Cp (IMSC) 0.3090 $IMSC

Implant Sciences Announces Conference Call Regarding Zapata Industries
PR Newswire - Mon Jul 25, 7:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced that it will be hosting a conference call today, Monday, July 25, 2016, at 4:15 PM EDT to provide additional information on the company's recent announcement that it signed a letter of intent to acquire Zapata Industries SAS of Marseilles, France. Zapata (http://www.zapata-industries.com) is a profitable and debt-free company with commercial, defense, and homeland security technology applications. Further information can be found on the company website at the following URL: http://www.implantsciences.com/zapata-industries-qa/.

Implant Sciences Announces Letter of Intent to Acquire Zapata Industries, Plan to Extinguish Debt and Uplist to NASDAQ
PR Newswire - Thu Jul 21, 7:15AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, is pleased to announce the signing of a letter of intent to acquire Zapata Industries SAS of Marseilles, France. Zapata is a profitable and debt-free company with commercial, defense, and homeland security technology applications.

Implant Sciences' ETDs Deployed to More Than 160 Airports over the Last Year
PR Newswire - Thu Jun 09, 3:01PM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced that its QS-B220 desktop explosives and drugs trace detector has been deployed to over 160 airports across the United States and Europe over the past twelve months. Over 1,000 units were sold to support ECAC demand to European airports in 14 countries, and substantial follow-on orders continue to be in play in the region.

Implant Sciences Reports Third Quarter Fiscal 2016 Financial Results
PR Newswire - Mon May 16, 3:05PM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2016.

Implant Sciences to Announce Third Quarter Fiscal 2016 Financial Results
PR Newswire - Thu May 12, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, will host a webcast and conference call on Monday, May 16, 2016 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2016.

Emerging Growth in Graphene 3D Printing Strong Growth Begins - Stocks Trending Now
ACCESSWIRE - Wed May 04, 7:02AM CDT
MIAMI, FL / ACCESSWIRE / May 4, 2016 / EmergingGrowth.com - Graphene 3D Lab, Inc. (OTCQB: GPHBF) reports triple digit increase in revenue over its previous quarter.

Implant Sciences Receives the 2016 DHS Small Business Achievement Award
PR Newswire - Mon May 02, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security applications, announced today that it is one of the 16 companies that have been selected by the Department of Homeland Security (DHS) to receive the 2016 DHS Small Business Achievement Award for its outstanding work in support of the DHS' stated mission to help ensure a homeland that is safe, secure, and resilient against terrorism and other hazards.

Implant Sciences Provides Additional Information on the Equity Component of Recent Credit Arrangement Extensions
PR Newswire - Tue Apr 12, 3:15PM CDT
Implant Sciences Corporation (OTCQB: IMSC) ("Implant Sciences" or the "Company" , a leading manufacturer of explosives trace detection (ETD) and drugs detection solutions for homeland security, today provided additional detail regarding the terms and conditions of the Company's recently extended secured credit arrangements with DMRJ Group, LLC ("DMRJ" and Montsant Partners LLC ("Montsant" and the group of investors represented by BAM Administrative Services, LLC ("BAM" .

Implant Sciences Extends Credit Agreements
PR Newswire - Thu Mar 31, 6:34PM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security, today announced the extension of its secured credit agreements with DMRJ Group, LLC ("DMRJ" and the group of investors represented by BAM Administrative Services, LLC ("BAM" .

Continuing ECAC Demand Leads to Follow-On Orders for European Nations as Implant Sciences Ships Additional $1 Million of ETDs Worldwide
PR Newswire - Thu Mar 31, 9:17AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for aviation and security applications, today announced that it has shipped approximately $1 million of its QS-B220 desktop explosives and drugs trace detectors and its QS-H150 handheld explosives trace detectors. A large portion of the sales, which were previously unannounced, were shipped to fulfill additional demand for aviation security in European nations. Over the past year, Implant Sciences has been selected by high profile airports across 14 EU nations and has deployed over 1,000 units to support ECAC regulations.

Implant Sciences to Announce Second Quarter Fiscal 2016 Financial Results
PR Newswire - Wed Feb 10, 2:06PM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, will host a webcast and conference call on Thursday, February 11, 2016 at 4:15 p.m. to discuss the financial results for the quarter ended December 31, 2015.

Implant Sciences Wins CATSA Order for 122 Explosives Trace Detectors
PR Newswire - Tue Jan 19, 9:52AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today reported that the company has received a previously unannounced order from the Canadian Air Transport Security Authority (CATSA) for up to 122 of its industry-leading QS-B220 desktop explosives trace detectors. These systems are planned to be deployed during the first half of 2016 (i.e., during Implant Sciences' current fiscal year ending June 30) to a number of Canadian airports for passenger and baggage screening.

Identifying Opportunity, Placing Risk - Complementary Research on New Wave Holdings, One Step Vending, Implant Sciences and Armanino Foods of Distinction
ACCESSWIRE - Tue Jan 19, 8:25AM CST
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: New Wave Holdings Inc. (OTC: NWAV), One Step Vending Corp. (OTC: KOSK), Implant Sciences Corp. (OTC: IMSC) and Armanino Foods of Distinction Inc. (OTC: AMNF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Implant Sciences Announces Worldwide Shipments of Over $5 Million
PR Newswire - Fri Jan 15, 10:21AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today reported that the company has shipped over $5 million of its explosives trace detectors (ETDs) across five continents over the past two months. These sales, which include a combination of QS-B220 desktop explosives and drugs trace detectors and QS-H150 handheld explosives trace detectors, do not include its TSA shipments, which have also begun to ship to airports across the United States.

Implant Sciences to Present at Noble Financial Capital Market's 12th Annual Investor Conference
PR Newswire - Tue Jan 12, 8:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, announced that the company's CEO, Dr. William McGann, and President, Robert Liscouski, will present a strategic business review at the NobleCon12 - Noble Financial Capital Markets' Twelfth Annual Investor Conference in Sandpiper Bay, Florida, on Monday, January 18, 2016 at 4:30pm EST. In their presentation, Dr. McGann and Mr. Liscouski will highlight the company's achievements in securing product sales contacts over the last 12 months as well as the company's plans for future growth.

Implant Sciences Announces First Shipment of ETD Systems for U.S. Airport Deployment
PR Newswire - Tue Dec 08, 8:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today reported that the Company has delivered its first shipment of QS-B220 desktop Explosives Trace Detectors (ETDs) to airports across the United States. These units are a part of the 1,170 unit order that was placed by the Transportation Security Administration (TSA) in November, 2014. The entirety of the 1,170 units is expected to be delivered across more than 40% of airports in the United States within Implant Sciences' fiscal year 2016, which began July 1, 2015.

Implant Sciences to Explore Strategic Options as Growing Security Needs for Soft Targets Drives Spending on Security Technologies
PR Newswire - Thu Dec 03, 8:45AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the its Board of Directors has authorized management to retain financial advisors to explore strategic alternatives to maximize shareholder value.

Implant Sciences to Exhibit at the 13th Transport Security Expo in London
PR Newswire - Mon Nov 30, 8:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced that it will exhibit at the 13th Transport Security Expo (Transec) from December 2-3, 2015 in London, United Kingdom. Implant Sciences will have its QS-B220 Desktop Explosives and Drugs Trace Detector available for demonstrations in booth G-1.

For the Third Consecutive Year, Implant Sciences' QS-B220 Wins the 2015 GSN Homeland Security Award for "Best Explosive Detection Product or Solution"
PR Newswire - Thu Nov 19, 8:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced that its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Homeland Security Award for " Best Explosive Detection Product or Solution" for the third year in a row. The QS-B220 also won the GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" in June 2015.

Implant Sciences' President Featured on CNN & BBC Regarding Russian Airline Incident
PR Newswire - Tue Nov 10, 10:20AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced that the company's President, Robert Liscouski, (also former Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security) appeared on CNN's Situation Room and BBC's World News America, commenting about aviation security and the Russian Metrojet Incident. He was also interviewed by Government Security News (GSN) and appeared in a featured article in the publication.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading